11:55 ETSino Biopharmaceutical Limited stellt neue globale Marke SBP Group vor, um die internationale Expansion zu beschleunigenprnewswire·6 hours ago01177-0.10%AZN+3.03%
Keymed Biosciences swings to FY26 H1 profit of RMB 1.22 billion; revenue rises 24% to RMB 617.07 millionPUBT·9 hours ago09926-1.87%AZN+3.03%
Sino Biopharma rebrands global operations under SBP Group identityPUBT·10 hours agoAZN+3.03%01177-0.10%
XtalPi swings to FY26 H1 net loss of RMB 224.94 million; revenue falls 23.87% to RMB 393.63 millionPUBT·12 hours ago02228-3.60%
SBP GROUP Interim Net Profit Rises 1.4% YoY to RMB3.43B; Div 7 HK CentsAASTOCKS News·13 hours ago01177-0.10%
Sino Biopharmaceutical: Revenue up 10.6% to RMB19.44B, driven by 44.3% growth in innovative drugs and out-licensingQuartr·13 hours ago01177-0.10%
BeOne Medicines and partners renew Brukinsa access programme for CLLPharmaceutical Technology·14 hours agoBGNE0.00%ONC+2.09%
M Stanley Raises INNOVENT BIO TP to HKD138.5 on Strong 1H Product RevenueAASTOCKS News·17 hours ago01801+1.66%
Aikobio’s AK0406 flu prevention drug wins China IND clearance for clinical trialsPUBT·1 day ago, 04:26 AM09926-1.87%
HSI Reverses to Close Up 17 Pts as BABA-W Gains Over 3% to Support Market; Z.AI Once Slips Below HKD1,000AASTOCKS News·1 day ago, 03:41 AMWXXWY+0.57%LNVGY-3.97%
WuXi Biologics wins BioPharma APAC spot on 2026 sustainable biopharma listPUBT·1 day ago, 02:05 AMWXXWY+0.57%02269-1.40%
WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMOPR Newswire·1 day ago, 02:04 AMWXXWY+0.57%02269-1.40%
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries | ONC Stock NewsStockTitan·1 day ago, 09:00 PMBGNE0.00%ONC+2.09%
